U.S. markets close in 12 minutes

Bio-Rad Laboratories, Inc. (BIO)

NYSE - Nasdaq Real Time Price. Currency in USD
Add to watchlist
786.35+0.83 (+0.11%)
As of 3:47PM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Commodity Channel Index

Commodity Channel Index

Previous Close785.51
Bid783.99 x 1100
Ask785.46 x 800
Day's Range781.14 - 791.39
52 Week Range490.73 - 832.70
Avg. Volume121,956
Market Cap23.428B
Beta (5Y Monthly)0.85
PE Ratio (TTM)5.87
EPS (TTM)134.05
Earnings DateOct 27, 2021 - Nov 01, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est856.25
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
-15% Est. Return
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Bio-Rad Laboratories, Inc.
    BIO: Lowering target price to $840.00BIO-RAD LABORATORIES-A has an Investment Rating of HOLD; a target price of $840.000000; an Industry Subrating of High; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Medium.
    Fair Value
    Economic Moat
    7 days agoArgus Research
View more